Page last updated: 2024-08-24

iopamidol and Diabetic Glomerulosclerosis

iopamidol has been researched along with Diabetic Glomerulosclerosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aspelin, P; Aubry, P; Davidson, C; Gietzen, F; Kumar, S; Laskey, W; Rudnick, M; Wiemer, M1
Solomon, R1
Ahmad, A; Aloisi, C; Catania, MA; Cuzzocrea, S; Di Paola, R; Esposito, E; Italiano, D; Mazzon, E; Mondello, P; Mondello, S1
Anselmino, M; Biondi-Zoccai, G; Sheiban, I1
Narasaki, K1
Fischer, A; Kollath, J; Rautschka, E; Riemann, H; Scherberich, JE1

Trials

2 trial(s) available for iopamidol and Diabetic Glomerulosclerosis

ArticleYear
Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
    American heart journal, 2009, Volume: 158, Issue:5

    Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Iopamidol; Kidney Failure, Chronic; Male; Triiodobenzoic Acids

2009
Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients.
    Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband, 1989, Volume: 128

    Topics: Aged; Angiography; Contrast Media; Diabetic Nephropathies; Diatrizoate Meglumine; Female; Humans; Iopamidol; Kidney; Male; Middle Aged; Risk Factors; Subtraction Technique

1989

Other Studies

4 other study(ies) available for iopamidol and Diabetic Glomerulosclerosis

ArticleYear
Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
    American heart journal, 2010, Volume: 159, Issue:2

    Topics: Chronic Disease; Contrast Media; Coronary Angiography; Diabetic Nephropathies; Humans; Inpatients; Iopamidol; Kidney Diseases; Triiodobenzoic Acids

2010
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine.
    European journal of pharmacology, 2012, Jan-15, Volume: 674, Issue:2-3

    Topics: Acetophenones; Acetylcysteine; Acute-Phase Proteins; Animals; Apoptosis; Contrast Media; Cytosine; Diabetic Nephropathies; Enzyme Activation; Enzyme Inhibitors; Glutathione Transferase; Iopamidol; Isoenzymes; Kidney Glomerulus; Lipocalin-2; Lipocalins; Male; NADPH Oxidases; Poly(ADP-ribose) Polymerases; Potassium; Proto-Oncogene Proteins; Rats; Rats, Wistar; Sodium; Time Factors; Tyrosine

2012
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
    Circulation, 2008, Feb-19, Volume: 117, Issue:7

    Topics: Angioplasty, Balloon, Coronary; Confounding Factors, Epidemiologic; Contrast Media; Coronary Angiography; Creatinine; Diabetic Nephropathies; Double-Blind Method; Humans; Incidence; Iopamidol; Kidney Diseases; Randomized Controlled Trials as Topic; Research Design; Risk; Sample Size; Sampling Studies; Triiodobenzoic Acids

2008
[Contrast-associated nephrotoxicity: ultrastructural and biochemical study in diabetic rats].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1997, Volume: 57, Issue:9

    Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diatrizoate; Iopamidol; Ioxaglic Acid; Kidney; Male; Rats; Rats, Wistar; Streptozocin; Triiodobenzoic Acids

1997